Integer Holdings Corp (ITGR)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Integer Holdings Corp.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 11 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Basics
Performance
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 19.5% below the current price.
- Consensus
- Strong Buy
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Next Reporting Date
- Expected Earnings per Share
- 1.38 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.90 | 16.40 | 450 | 11.10 | 7.30 | 63 | 44 |
| 2025: Q1 | -0.66 | -213.40 | 436 | 7.00 | -5.20 | 31 | 6 |
| 2025: Q2 | 1.04 | 17.80 | 473 | 10.50 | 7.80 | 44 | 25 |
| 2025: Q3 | 1.11 | 12.50 | 467 | 8.10 | 8.50 | 66 | 46 |
| 2025: Q4 | 1.38 | 53.30 | 471 | 4.80 | 10.30 | 55 | 28 |
| 2026: Q1 | 0.48 | – | 440 | 0.80 | 3.80 | 25 | 1 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
Integer Holdings Corporation ist als Auftragsentwicklungs- und -fertigungsunternehmen für Medizinprodukte in den USA, Costa Rica, Puerto Rico, Irland und international tätig. Das Unternehmen bietet Produkte für interventionelle Kardiologie, strukturelle Herzerkrankungen, Herzinsuffizienz, periphere Gefäße, n…
| CEO Insider Trades (12 Mo.) | buying own stock |
|---|---|
| Employees | 11,000 |
| Headquarters | Plano, TX |
| Website | integer.net |
| IPO Date | 29. Sep 2000 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Payman Khales | CEO, President & Director | 1970 |
| Diron Smith | Executive VP & CFO | 1974 |
| Lindsay Krause Blackwood J.D. | Senior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary | 1977 |
| Andrew Senn | President of Cardio & Vascular | 1982 |
| Jim Stephens | President of Cardiac Rhythm Management & Neuromodulation | 1974 |
| Tom P. Thomas | VP, Corporate Controller & Principal Accounting Officer | 1971 |
| Carol Russell | VP & Chief Information Officer | – |
| Kristen Marie Stewart C.F.A. | Director of Investor Relations | – |
| Kirk K. Thor Ph.D. | Executive VP & Chief Human Resources Officer | 1964 |
| John Harris | Executive Vice President of Global Operations & Manufacturing Strategy | 1960 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.